1 change Urgent, last 7 days

Doliprane Suspension Recall Due to Pipette Wear-Off

The French Agency for the Safety of Medicines and Health Products (ANSM) has announced a recall of 27 lots of Doliprane 2.4% oral suspension due to a manufacturing defect causing pipette graduations to wear off. This defect poses a risk of incorrect dosage and potential overdose in infants and young children.

Urgent Notice Product Safety

Get alerts for ""

We'll email you when new changes match this search.

Free. Unsubscribe anytime.